Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-17

Clinical Trial Update: Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years [Phase 1]

View source ↗

Summary

A Phase 1 trial to evaluate the EuHZV vaccine in healthy adults aged 50 to 69 years is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EuHZV

Snippet

Sponsor: EuBiologics Co.,Ltd | Conditions: Varicella Zoster Virus Infection, Herpes Zoster | Phase 1 | Status: ACTIVE_NOT_RECRUITING